The serum proteomics tracking of hepatocellular carcinoma early recurrence following radical resection
暂无分享,去创建一个
Ying Sun | Xiaolong Liu | Bixing Zhao | Jingfeng Liu | Xiaomo Wu | Yongyi Zeng | Geng Chen | Hongzhi Liu | Ying-chao Wang | Xiaohua Xing | Hui Chen
[1] Ping Chen,et al. The prognostic correlation of AFP level at diagnosis with pathological grade, progression, and survival of patients with hepatocellular carcinoma , 2017, Scientific Reports.
[2] W. Chapman,et al. Prediction of Hepatocellular Carcinoma Recurrence Beyond Milan Criteria After Resection: Validation of a Clinical Risk Score in an International Cohort , 2017, Annals of surgery.
[3] H. Xie,et al. PGK1 Drives Hepatocellular Carcinoma Metastasis by Enhancing Metabolic Process , 2017, International journal of molecular sciences.
[4] T. Frankel,et al. Recurrence of hepatocellular carcinoma at surgical incision site: case series and review of literature , 2017, Annals of the Royal College of Surgeons of England.
[5] Ben C. Collins,et al. Quantitative proteomics: challenges and opportunities in basic and applied research , 2017, Nature Protocols.
[6] J. Rowe,et al. Review of hepatocellular carcinoma: Epidemiology, etiology, and carcinogenesis , 2017, Journal of carcinogenesis.
[7] A. Braillon. Recurrence in Early-Stage Hepatocellular Carcinoma: CpG Methylation and Smoking. , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[8] Jiayin Yang,et al. Liver resection versus liver resection plus TACE for patients with hepatocellular carcinoma beyond Milan criteria. , 2017, The Journal of surgical research.
[9] K. Wakayama,et al. Huge hepatocellular carcinoma greater than 10 cm in diameter worsens prognosis by causing distant recurrence after curative resection , 2017, Journal of surgical oncology.
[10] G. Raimondo,et al. Does the margin width influence recurrence rate in liver surgery for hepatocellular carcinoma smaller than 5 cm? , 2017, European review for medical and pharmacological sciences.
[11] Xiaolong Liu,et al. Reveal the molecular signatures of hepatocellular carcinoma with different sizes by iTRAQ based quantitative proteomics. , 2017, Journal of proteomics.
[12] K. Aldape,et al. Mitochondria-Translocated PGK1 Functions as a Protein Kinase to Coordinate Glycolysis and the TCA Cycle in Tumorigenesis. , 2016, Molecular cell.
[13] G. Goh,et al. Changing epidemiology of hepatocellular carcinoma in Asia. , 2015, Best practice & research. Clinical gastroenterology.
[14] Amit G Singal,et al. Hepatocellular Carcinoma From Epidemiology to Prevention: Translating Knowledge into Practice. , 2015, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[15] Rui Zhu,et al. LC‐MS/MS‐based serum proteomics for identification of candidate biomarkers for hepatocellular carcinoma , 2015, Proteomics.
[16] M. Schwartz,et al. Recurrence of hepatocellular cancer after resection: patterns, treatments, and prognosis. , 2015, Annals of surgery.
[17] D. Pang,et al. Phosphoglycerate kinase-1 is a predictor of poor survival and a novel prognostic biomarker of chemoresistance to paclitaxel treatment in breast cancer , 2015, British Journal of Cancer.
[18] C. Mathers,et al. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012 , 2015, International journal of cancer.
[19] Wei Zhang,et al. Arginase-1 is a more sensitive marker than HepPar-1 and AFP in differential diagnosis of hepatocellular carcinoma from nonhepatocellular carcinoma , 2015, Tumor Biology.
[20] S. Reddy,et al. Reactive oxygen species in inflammation and tissue injury. , 2014, Antioxidants & redox signaling.
[21] Yin-kun Liu,et al. High-throughput screening of tumor metastatic-related differential glycoprotein in hepatocellular carcinoma by iTRAQ combines lectin-related techniques , 2013, Medical Oncology.
[22] M. Bantscheff,et al. High-resolution enabled TMT 8-plexing. , 2012, Analytical chemistry.
[23] Yan Li,et al. FLNA and PGK1 are Two Potential Markers for Progression in Hepatocellular Carcinoma , 2011, Cellular Physiology and Biochemistry.
[24] W. Chapman,et al. Surgical treatment of hepatocellular carcinoma: expert consensus statement. , 2010, HPB : the official journal of the International Hepato Pancreato Biliary Association.
[25] H. Northoff,et al. PGK1 a Potential Marker for Peritoneal Dissemination in Gastric Cancer , 2008, Cellular Physiology and Biochemistry.
[26] K. Shirabe,et al. Clinicopathological risk factors linked to recurrence pattern after curative hepatic resection for hepatocellular carcinoma--results of 152 resected cases. , 2007, Hepato-gastroenterology.
[27] Ying Liang,et al. Overexpression and elevated serum levels of phosphoglycerate kinase 1 in pancreatic ductal adenocarcinoma , 2006, Proteomics.
[28] A. Tall,et al. High Density Lipoprotein (HDL) Particle Uptake Mediated by Scavenger Receptor Class B Type 1 Results in Selective Sorting of HDL Cholesterol from Protein and Polarized Cholesterol Secretion* , 2001, The Journal of Biological Chemistry.
[29] N. Fidge. High density lipoprotein receptors, binding proteins, and ligands. , 1999, Journal of lipid research.
[30] A. Jemal,et al. Cancer statistics, 2018 , 2018, CA: a cancer journal for clinicians.
[31] D. Goodlett,et al. Mass Spectrometry-Based Serum Proteomics for Biomarker Discovery and Validation. , 2017, Methods in molecular biology.
[32] Wu Xinhua. Clinical values of combined hepatoma-specific α-fetoprotein (AFP) fraction and AFP-mRNA determination in diagnosis and differentiation of hepatocellular carcinoma , 2006 .